Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population

N/ACompletedNCT00819273

AstraZeneca1,700 enrolled

Overview

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Study Type

OBSERVATIONAL

Enrollment

1,700

Conditions

hsCRP

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects with at least one clinic visit record within the last 12 months from the date of data entry. * Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry. Exclusion Criteria: * Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement * Active inflammatory diseases documented during the period of CRP measurement * Subjects taking immunosuppressants * Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease

Locations (10)

Research Site

Wŏnju, Gangwon-do, South Korea

Research Site

Anyang-si, Gyeonggi-do, South Korea

Research Site

Goyang-si, Gyeonggi-do, South Korea

Research Site

Uijeongbu-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Evaluate hs-CRP levels according to risk categories by the NCEP ATP III.

Time frame: Within the last 12 months from the date of data entry.

Secondary Outcomes

Evaluate a relationship between hs-CRP and each CHD CVD risk factor including LDL-C.

Time frame: Within the last 12 months from the date of data entry.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.